UW Carbone Cancer Center receives SPORE designation, federal grant to support prostate cancer research
University of Wisconsin Carbone Cancer Center will be designated as a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute (NCI) for research initiatives to advance new prostate cancer treatments.
Federal agency uses UW–Madison Neighborhood Atlas research to shape national health policy
A data tool developed by UW–Madison researchers showing health-relevant metrics for every neighborhood in the United States is guiding a national model to help Medicare beneficiaries from under-resourced communities access health care more effectively.
Lupus much more likely to cause cardiovascular problems in Black patients
A population-based study of the autoimmune disease lupus in Black patients shows that the risk of cardiovascular disease is strikingly high in young patients –19 times higher than in non-Blacks in the first 12 years after diagnosis – and may be predicted by a characteristic rash.
UW study focuses on Alzheimer’s disease treatment and prevention in Black adults
As the first of a new generation of Alzheimer’s disease drugs hit the market, some researchers are troubled by the lack of clinical data available on the effectiveness of these drugs in Black people.
UW–Madison joins national harm reduction research network to prevent overdose deaths
To build upon existing research and develop new strategies in harm reduction, the National Institutes of Health (NIH) has established a national research network to evaluate harm reduction services. The network will include a coordinating center and nine research studies at institutions across the country, including at the University of Wisconsin–Madison.
Alzheimer’s, related dementias cause high economic burden among Indigenous populations
Indigenous people living in Wisconsin and throughout the nation experience significant health and financial burden from Alzheimer’s disease and related dementias, according to new research published by a University of Wisconsin–Madison team and collaborators.
New study finds disparities in cardiac arrhythmia treatment
A large, population-based study has found cardiac ablation for ventricular tachycardia (VT) procedures is more likely to be performed on patients who are white males from wealthier neighborhoods.
Innovative clinical trial targets recurrent BK infection in kidney transplant recipients
Kidney transplant patients like Tessa Adolph, from Rockford, Illinois, face an age-old problem to protect their new kidney and bodies after transplant surgery: how to prevent infections while also safeguarding their new kidney from damage or rejection.
Antibody treatment reduces asthma attacks in children living in disadvantaged urban areas
A monoclonal antibody drug called mepolizumab decreased asthma attacks by 27% in children and adolescents who have a form of severe asthma, are prone to asthma attacks and live in low-income urban neighborhoods, according to a clinical trial sponsored and co-funded by the National Institutes of Health. The majority of the trial’s participants were Black and/or Hispanic—populations that have been under-represented in clinical trials and are at greatest risk for morbidity and mortality from asthma.
Black patients in Wisconsin 50% less likely to be treated for pancreatic cancer
Black patients with pancreatic cancer have lower survival rates than white patients, and a new study suggests why: They are much less likely to receive life-extending treatments.
Study finds higher asthma rates among Black and Hispanic children regardless of neighborhood income or density
A new, large study found that although there is a correlation between childhood asthma and being born into a densely populated or lower-income neighborhood, Black and Hispanic children had consistently higher rates of asthma than white children even in more affluent neighborhoods.
Future of health: Cancer vaccines
When people consider vaccines, many think about the pandemic and about preventing illness. However, certain UW researchers have a very different focus when they work with vaccines.